Details for New Drug Application (NDA): 088913
✉ Email this page to a colleague
NDA 088913 describes PHERAZINE DM, which is a drug marketed by Halsey and is included in one NDA. Additional details are available on the PHERAZINE DM profile page.
The generic ingredient in PHERAZINE DM is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.
The generic ingredient in PHERAZINE DM is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-three drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.
Summary for 088913
| Tradename: | PHERAZINE DM |
| Applicant: | Halsey |
| Ingredient: | dextromethorphan hydrobromide; promethazine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 15MG/5ML;6.25MG/5ML | ||||
| Approval Date: | Mar 2, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
